In response to Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease

Jerome R. Lechien; Petros D. Karkos; Bernard Harmegnies; Sven Saussez

doi:10.1002/lary.27185

In response to Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease

The Laryngoscope ◽

10.1002/lary.27185 ◽

2018 ◽

Vol 128 (10) ◽

pp. E349-E350

Author(s):

Jerome R. Lechien ◽

Petros D. Karkos ◽

Bernard Harmegnies ◽

Sven Saussez

Keyword(s):

Reflux Disease ◽

Laryngopharyngeal Reflux ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Laryngopharyngeal Reflux Disease

Download Full-text

Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease

The Laryngoscope ◽

10.1002/lary.27111 ◽

2018 ◽

Vol 128 (10) ◽

pp. 2252-2260 ◽

Cited By ~ 13

Author(s):

Wen-Hsuan Tseng ◽

Ping-Huei Tseng ◽

Jia-Feng Wu ◽

Ya-Chin Hsu ◽

Ting-Yi Lee ◽

...

Keyword(s):

Reflux Disease ◽

Laryngopharyngeal Reflux ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Laryngopharyngeal Reflux Disease

Download Full-text

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Cited By ~ 22

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study

World Journal of Gastroenterology ◽

10.3748/wjg.v21.i16.5023 ◽

2015 ◽

Vol 21 (16) ◽

pp. 5023 ◽

Cited By ~ 6

Author(s):

Takayoshi Suzuki

Keyword(s):

Reflux Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Irsogladine Maleate

Download Full-text

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety

The American Journal of Gastroenterology ◽

10.1111/j.1572-0241.2001.03443.x ◽

2001 ◽

Vol 96 (1) ◽

pp. 27-34 ◽

Cited By ~ 95

Author(s):

David A. Johnson ◽

Stanley B. Benjamin ◽

Nimish B. Vakil ◽

Jay L. Goldstein ◽

Mark Lamet ◽

...

Keyword(s):

Gastroesophageal Reflux Disease ◽

Gastroesophageal Reflux ◽

Reflux Disease ◽

Erosive Esophagitis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Disease Symptoms ◽

Double Blind Placebo

Download Full-text

Efficacy of three proton‐pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double‐blind study

Clinical Otolaryngology ◽

10.1111/coa.13345 ◽

2019 ◽

Vol 44 (4) ◽

pp. 612-618 ◽

Cited By ~ 3

Author(s):

Young Hoon Yoon ◽

Ki Wan Park ◽

Seung Hun Lee ◽

Hee Sung Park ◽

Jae Won Chang ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Proton Pump ◽

Reflux Disease ◽

Laryngopharyngeal Reflux ◽

Therapeutic Strategies ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Laryngopharyngeal Reflux Disease

Download Full-text

Mo1069 Efficacy of Addition of Irsogladine Maleate to Rabeprazole in the Treatment of Patients With Non-Erosive Reflux Disease - A Double-Blind, Placebo-Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(13)62103-4 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-568

Author(s):

Takayoshi Suzuki ◽

Masashi Matsushima ◽

Muneki Igarashi ◽

Jun Koike ◽

Tetsuya Mine

Keyword(s):

Reflux Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Irsogladine Maleate

Download Full-text

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease - a double-blind, placebo-controlled study

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04517.x ◽

2010 ◽

Vol 33 (3) ◽

pp. 323-332 ◽

Cited By ~ 42

Author(s):

H. Miwa ◽

K. Inoue ◽

K. Ashida ◽

T. Kogawa ◽

A. Nagahara ◽

...

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mosapride Citrate

Download Full-text

T1081 Efficacy of Addition of Prokinetics, Mosapride Citrate, On Omeprazole in Treatment of Patients with Non-Erosive Reflux Disease - A Randomized Double-Blind Placebo-Controlled Study-

Gastroenterology ◽

10.1016/s0016-5085(09)62280-0 ◽

2009 ◽

Vol 136 (5) ◽

pp. A-495

Author(s):

Hiroto Miwa ◽

Kazuhiko Inoue ◽

Kiyoshi Ashida ◽

Takafumi Kogawa ◽

Akihito Nagahara ◽

...

Keyword(s):

Reflux Disease ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mosapride Citrate

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

105: The Efficacy of Cernilton® in Patients with Chronic Pelvic Pain Syndrome (CP/CPPS) Type Nih IIIA: A Randomized, Prospective, Double-Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/s0022-5347(18)32372-3 ◽

2006 ◽

Vol 175 (4S) ◽

pp. 34-34 ◽

Cited By ~ 3

Author(s):

Henning Schneider ◽

Martin Ludwig ◽

Andreas Horstmann ◽

Jörg Schnitker ◽

Wolfgang Weidner

Keyword(s):

Pelvic Pain ◽

Chronic Pelvic Pain ◽

Chronic Pelvic Pain Syndrome ◽

Pain Syndrome ◽

Controlled Study ◽

Pelvic Pain Syndrome ◽

Double Blind ◽

Double Blind Placebo

Download Full-text